Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousStem Cell TransplantationHematopoietic Stem CellsBone MarrowTransplantation, AutologousGraft vs Host DiseaseBone Marrow CellsTransplantation ConditioningLiver TransplantationStem CellsPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsTransplantation ChimeraKidney TransplantationWhole-Body IrradiationTissue DonorsTreatment OutcomeGraft SurvivalImmunosuppressive AgentsBusulfanLeukemiaHistocompatibility TestingRetrospective StudiesBone and BonesHistocompatibilityHematopoiesisGraft RejectionCord Blood Stem Cell TransplantationRecurrenceHeart TransplantationTime FactorsAnemia, AplasticCombined Modality TherapyRemission InductionMyeloablative AgonistsHematopoietic Stem Cell MobilizationCell DifferentiationMesenchymal Stem Cell TransplantationAntigens, CD34CyclophosphamideGraft vs Leukemia EffectLeukemia, Myeloid, AcuteTransplantation, IsogeneicMultiple MyelomaHepatic Veno-Occlusive DiseaseCell TransplantationMice, Inbred C57BLTransplantation ImmunologyChimerismHematologic DiseasesBone Marrow PurgingMyelodysplastic SyndromesHLA AntigensBone Marrow DiseasesSurvival AnalysisMelphalanLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival RateDisease-Free SurvivalGraft vs Tumor EffectLymphocyte TransfusionColony-Forming Units AssayFlow CytometrySevere Combined ImmunodeficiencyEmbryonic Stem CellsCell LineageLymphocyte DepletionAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorAdult Stem CellsImmunosuppressionAcute DiseaseT-LymphocytesVidarabineCells, CulturedFollow-Up StudiesSiblingsLung TransplantationCytomegalovirus InfectionsLeukemia, MyeloidStem Cell NicheBone Marrow ExaminationRadiation ChimeraSalvage TherapyOrgan TransplantationProspective StudiesAntilymphocyte SerumMesenchymal Stromal CellsUnrelated DonorsCell SeparationCytarabineBone RemodelingPrognosisCyclosporineFetal BloodTransplantation